Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cancer Therapies02:49

Cancer Therapies

9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

935
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
935

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inverse Statistics of Active Matter Trajectories to Distinguish Interaction Kernel Anisotropy from Emergent Correlations.

Bulletin of mathematical biology·2026
Same author

Optimal experiment design for practical parameter identifiability and model discrimination.

Mathematical biosciences·2026
Same author

Modeling Collective Cell Migration in a Data-Rich Age: Challenges and Opportunities for Data-Driven Modeling.

Cold Spring Harbor perspectives in biology·2026
Same author

A likelihood-based Bayesian inference framework for the calibration of and selection between stochastic velocity-jump models.

Journal of the Royal Society, Interface·2026
Same author

The influence of cell phenotype on collective cell invasion into the extracellular matrix.

Bulletin of mathematical biology·2025
Same author

Optimal experimental design for parameter estimation in the presence of observation noise.

Mathematical biosciences·2025

Related Experiment Video

Updated: Jan 6, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.7K

Optimal Control in Combination Therapy for Heterogeneous Cell Populations with Drug Synergies.

Simon F Martina-Perez1, Samuel W S Johnson2, Rebecca M Crossley3

  • 1School of Medicine and Biomedical Sciences, University of Oxford, Oxford, UK. simon.martina-perez@medschool.ox.ac.uk.

Bulletin of Mathematical Biology
|October 14, 2025
PubMed
Summary

This study presents an optimal control framework to optimize multi-drug cancer treatments for heterogeneous cell populations. It addresses challenges in predicting patient responses to complex drug combinations.

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.4K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.5K

Related Experiment Videos

Last Updated: Jan 6, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.7K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.4K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.5K

Area of Science:

  • Mathematical Biology
  • Computational Oncology
  • Pharmacodynamics

Background:

  • Cell heterogeneity significantly impacts patient responses to cancer drug treatments, often correlating with poor outcomes.
  • Optimizing multi-drug therapies for heterogeneous cell populations, considering drug synergies, remains a critical challenge in oncology.

Purpose of the Study:

  • To introduce and analyze a general optimal control framework for modeling treatment responses in multiple cell populations under multi-drug interactions.
  • To derive general results for optimal solutions within this framework and explore the translation of mathematical optimality to clinical outcomes.

Main Methods:

  • Utilizing a system of coupled semi-linear ordinary differential equations to model the effects of multiple drugs on cell populations.
  • Developing and applying a general optimal control framework to analyze treatment dynamics.
  • Deriving general results for optimal solutions and applying them to canonical examples.

Main Results:

  • The framework provides a method to model and analyze the complex interactions between multiple drugs and heterogeneous cell populations.
  • General results for optimal solutions were derived, offering insights into treatment optimization strategies.
  • A systematic approach was introduced to propose distinct classes of drug dosing strategies inspired by optimal control theory.

Conclusions:

  • The developed optimal control framework offers a powerful tool for understanding and optimizing multi-drug cancer therapies in the context of cell heterogeneity.
  • The study bridges mathematical optimality with clinically relevant outcomes, paving the way for novel drug dosing strategies.
  • This work contributes to advancing precision medicine by providing a framework for personalized and effective cancer treatment regimens.